Cancer

A severe case of COVID-19 leads to a life-saving lung cancer diagnosis

Joan Lennie pays it forward to RUSH breast cancer surgery patients

Support from her care team made Diane's breast cancer treatment easier

How Laura and Kurt Hagemann helped each other face breast cancer

Pete Batra, MD, the Chair of the Department of Otorhinolaryngology – Head and Neck Surgery at Rush University Medical Center, highlights Rush’s unparalleled expertise, its use of leading-edge treatments and how it’s developing novel therapies for rare types of cancers.

RUSH Digestive Diseases physician Faraz Bishehsari, MD, PhD, receives Director’s Transformative Research Award

Rounding at Rush welcomes John O’Toole, MD, to the show to discuss spinal tumor care at Rush University Medical Center. Rush is known for its use of minimally invasive procedures, interdisciplinary nature that streamlines care and success in creating better quality of life outcomes for its patients.

The Rush Cancer Center has a deep commitment to accelerating innovations that bring cutting edge research to the bedside. Two examples of those innovations that Steven Gitelis, MD, and Rush have an active role in developing are 3-D printed models, which can help to preserve healthy tissue when treating benign and malignant bone and soft tissue tumors, and hybrid cold plasma, which can help stop the recurrence of cancer after surgery.

Kristina had a great support system to help her through cancer treatment. Now she wants to help others

Erik Schadde, MD, FACS, FEBS (HPB), a transplant surgeon at RUSH University Medical Center, spearheaded the creation of the DRAGON trials - large, multicenter, international trials that are evaluating the use of combined portal and hepatic vein, or double vein, embolization, to treat advanced liver cancer and metastases.